indobufen has been researched along with thromboxanes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catalano, I; Cosentino, F; Custro, N; Davì, G; Ganci, A; Giammarresi, C; Notarbartolo, A; Patrono, C | 1 |
| Banfi, C; Barbieri, SS; Brambilla, M; Colli, S; Eligini, S; Saliola, M; Tremoli, E; Violi, F | 1 |
1 trial(s) available for indobufen and thromboxanes
| Article | Year |
|---|---|
Inhibition of thromboxane biosynthesis and platelet function by indobufen in type II diabetes mellitus.
Topics: Aged; Blood Platelets; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Thromboxanes | 1993 |
1 other study(ies) available for indobufen and thromboxanes
| Article | Year |
|---|---|
Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism.
Topics: Cells, Cultured; Cyclooxygenase Inhibitors; Depression, Chemical; Dinoprostone; Flow Cytometry; Humans; Isoindoles; Lipopolysaccharides; Monocytes; Phenylbutyrates; Thromboplastin; Thromboxane A2; Thromboxane B2; Thromboxanes | 2006 |